United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - terbinafine hydrochloride (unii: 012c11zu6g) (terbinafine - unii:g7riw8s0xp) - terbinafine 250 mg

United States - English - NLM (National Library of Medicine)

american health packaging - terbinafine hydrochloride (unii: 012c11zu6g) (terbinafine - unii:g7riw8s0xp) - terbinafine 250 mg

Canada - English - Health Canada

abbvie corporation - ritonavir - capsule - 100mg - ritonavir 100mg - hiv protease inhibitors

Canada - English - Health Canada

abbvie corporation - ritonavir - solution - 80mg - ritonavir 80mg - hiv protease inhibitors

Canada - English - Health Canada

abbvie corporation - pibrentasvir; glecaprevir - tablet - 40mg; 100mg - pibrentasvir 40mg; glecaprevir 100mg - hcv protease inhibitors

Canada - English - Health Canada

abbvie corporation - glecaprevir; pibrentasvir - granules - 50mg; 20mg - glecaprevir 50mg; pibrentasvir 20mg - hcv protease inhibitors

Canada - English - Health Canada

sanofi-aventis canada inc - rifampin; isoniazid; pyrazinamide - tablet - 120mg; 50mg; 300mg - rifampin 120mg; isoniazid 50mg; pyrazinamide 300mg - antituberculosis agents

Canada - English - Health Canada

abbvie corporation - ritonavir - capsule - 100mg - ritonavir 100mg - hiv protease inhibitors

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - voriconazole -

New Zealand - English - Medsafe (Medicines Safety Authority)

neo health (nz) limited - voriconazole 200mg - powder for injection - 200 mg - active: voriconazole 200mg excipient: hydrochloric acid hydroxypropyl-beta-cyclodextrin sodium chloride water for injection - voriconazole is indicated for treatment of the following fungal infections: · invasive aspergillosis. · serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). · serious fungal infections caused by scedosporium spp. and fusarium spp. · other serious fungal infections, in patients intolerant of, or refractory to, other therapy.